MPWT
NAUT icon

MassMutual Private Wealth & Trust’s Nautilus Biotechnolgy NAUT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-156
Closed – – 1860
2022
Q4 		$0 Buy
+156
New +$301 ﹤0.01% 1775

Other funds holding NAUT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

MassMutual Private Wealth & Trust's NAUT Position: Q1 2023 in Review

MassMutual Private Wealth & Trust sold out of Nautilus Biotechnolgy (NAUT) in Q1 2023, closing a stake of 156 shares.

MassMutual Private Wealth & Trust first reported a position in NAUT in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2023.

  • MassMutual Private Wealth & Trust reported no remaining Nautilus Biotechnolgy position as of Q1 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 156 Nautilus Biotechnolgy shares in Q1 2023.
  • MassMutual Private Wealth & Trust first reported a position in Nautilus Biotechnolgy in Q4 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Nautilus Biotechnolgy position peaked at $0 in Q4 2022.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2023, filed 11 Apr 2023.